Apellis Pharmaceuticals Inc (APLS): Eigentümerstruktur Nicht notiert
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 40,923 US Dollar | 10 | 4 | 8 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 128.021.277 | 12,55 | 1,15 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Apellis Pharmaceuticals Inc
Mitarbeiter 733
Handelsplatz NASDAQ
Ticker Symbol APLS
IPO Datum 2017-11-09
Adresse 100 Fifth Avenue, Waltham, MA, United States, 02451
Webseite https://apellis.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Cedric Francois M.D., Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Mr. Alec Machiels J.D., MBA | Co-Founder & Director |
| 3 | Mr. Timothy E. Sullivan | CFO & Treasurer |
| 4 | Mr. David O. Watson Esq., J.D. | General Counsel & Secretary |
| 5 | Ms. Kelley Boucher | Chief People Officer |
| 6 | Dr. Caroline R. Baumal M.D. | Chief Medical Officer |
| 7 | Dr. Pascal Deschatelets Ph.D. | Co-Founder & Chief Scientific Officer |
| 8 | Mr. James G. Chopas CPA | VP, Corporate Controller & Chief Accounting Officer |
| 9 | Ms. Eva Stroynowski | Head of Investor Relations |
| 10 | Prof. Peter Hillmen M.D., Ph.D. | Head of Hematology Engagement & Member of PNH Scientific Advisory Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 10,57% | 0,56 Mrd. USD |
| 2 | venBio Select Advisor LLC | 9,55% | 0,50 Mrd. USD |
| 3 | Morgan Stanley - Brokerage Accounts | 7,84% | 0,41 Mrd. USD |
| 4 | State Street Corp | 5,35% | 0,28 Mrd. USD |
| 5 | UBS Group AG | 4,85% | 0,26 Mrd. USD |
| 6 | Vanguard Portfolio Management, LLC | 4,22% | 0,22 Mrd. USD |
| 7 | Pentwater Capital Management LP | 4,10% | 0,22 Mrd. USD |
| 8 | Vanguard Capital Management, LLC | 3,73% | 0,20 Mrd. USD |
| 9 | Point72 Asset Management, L.P. | 3,27% | 0,17 Mrd. USD |
| 10 | RTW INVESTMENTS, LLC | 2,88% | 0,15 Mrd. USD |
| 11 | HBK INVESTMENTS L P | 2,77% | 0,15 Mrd. USD |
| 12 | Suvretta Capital Management, LLC | 2,75% | 0,14 Mrd. USD |
| 13 | Geode Capital Management, LLC | 1,62% | 0,09 Mrd. USD |
| 14 | JPMorgan Chase & Co | 1,60% | 0,08 Mrd. USD |
| 15 | The Goldman Sachs Group Inc | 1,55% | 0,08 Mrd. USD |
| 16 | Balyasny Asset Management LLC | 1,50% | 0,08 Mrd. USD |
| 17 | Glazer Capital, LLC | 1,01% | 0,05 Mrd. USD |
| 18 | Test Hedge Fund Mgmt | 0,98% | 0,05 Mrd. USD |
| 19 | The Toronto-Dominion Bank | 0,97% | 0,05 Mrd. USD |
| 20 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0,94% | 0,05 Mrd. USD |